DETECTION OF VARICELLA-ZOSTER VIRUS IN RASH [SAMPLES BY] GENETICS [ANALYSIS THAT COLLECTED FROM] PATIENTS IN [BABYLON PROVINCE]
Journal: International Journal of Advanced Research (Vol.12, No. 04)Publication Date: 2024-04-18
Authors : Zahraa Abd Al Kareem; Rabab J.H AL-Hasseny;
Page : 841-844
Keywords : Rabab J.H Alhasseny Varicella-Zoster Virus Rash;
Abstract
The Varicella-zoster virus (VZV), also known as human herpesvirus 3 (HHV-3), is any_-herpesvirus that is the etiological agent of varicella (chickenpox) as a primary infection and herpes zoster (shingles) as a recurring infection. The 185 samples from two patients were subjected for specimen which include both skin sites for the sampling was forehead from both sexes and the age of patient was 17 and 18 years. These patients were diagnosed by dermatology doctor , rendering to the signs and indications,, in addition to be having hazard reasons that were determined by the evidence almost patients. In this study, patients with recent custom of local antibiotic treatment and usage beautifying substantial were excluded from sampling. The results was in total of 185 sample collected from patients suffering from rash. Detected the viruses were 107(57,8%)samples and other microorganisms were 78 (42,2%). The other microorganisms may by bacteria such as Streptococcus, Staphylococcus, Coranybacterum And Clostridium. But the 57,8% samples detected as a DNA viruses by viral infection kit.. of percentages for the Varicella-zoster virus was 86(80.37%) but other viruses were 21(19.63%) that detected by metagenomic analysis.
Other Latest Articles
- POPULATION’S ATTITUDE IN THE REPUBLIC OF BELARUS TO THE USE OF IN VITRO FERTILIZATION
- POSSIBILITIES TO IMPROVE TREATMENT RESULTS IN PATIENTS WITH CHRONIC PLEURAL EMPYEMA ACCOMPANIED BY BRONCHOPLEURAL FISTULAS
- SOLUBILITY AND BIOMINERALIZATION ABILITY OF PMMA BONE CEMENT NANOCOMPOSITE FILLED WITH 40% NANOHYDROXYAPATITE FOR USE AS ROOT-END FILLING MATERIAL
- CURRENT TRENDS IN ANTIBIOTIC RESISTANCE OF PATHOGENIC MICROORGANISMS IN SURGICAL PATIENTS
- THE POTENTIAL OF USING THE DYNAMICS OF ELECTROCARDIOGRAPHIC PARAMETERS IN DETECTING CARDIOTOXICITY 12 MONTHS AFTER THE END OF CHEMOTHERAPY FOR BREAST CANCER WITH DOXORUBICIN
Last modified: 2024-05-20 20:26:11